Davis R M Inc. maintained its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,585 shares of the medical equipment provider’s stock at the end of the second quarter. Davis R M Inc.’s holdings in Zimmer Biomet Holdings were worth $332,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Enterprise Financial Services Corp boosted its stake in shares of Zimmer Biomet Holdings by 0.3% in the second quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock valued at $340,000 after buying an additional 9 shares during the last quarter. Alpha Windward LLC boosted its stake in shares of Zimmer Biomet Holdings by 1.1% in the first quarter. Alpha Windward LLC now owns 1,651 shares of the medical equipment provider’s stock valued at $202,000 after buying an additional 18 shares during the last quarter. Sandy Spring Bank boosted its stake in shares of Zimmer Biomet Holdings by 1.7% in the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after buying an additional 20 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of Zimmer Biomet Holdings by 2.7% in the first quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock valued at $102,000 after buying an additional 22 shares during the last quarter. Finally, Cleararc Capital Inc. boosted its stake in shares of Zimmer Biomet Holdings by 0.5% in the first quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after buying an additional 25 shares during the last quarter. 83.62% of the stock is currently owned by hedge funds and other institutional investors.

Zimmer Biomet Holdings, Inc. (NYSE ZBH) opened at 117.19 on Tuesday. Zimmer Biomet Holdings, Inc. has a 52-week low of $95.63 and a 52-week high of $133.49. The firm’s 50-day moving average is $127.65 and its 200 day moving average is $121.39. The stock has a market capitalization of $23.65 billion, a PE ratio of 33.38 and a beta of 1.20.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by $0.02. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The firm had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.95 billion. During the same period in the previous year, the company posted $2.02 EPS. The firm’s revenue for the quarter was up 1.1% on a year-over-year basis. On average, equities analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be paid a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 0.82%. Zimmer Biomet Holdings’s payout ratio is presently 27.59%.

ILLEGAL ACTIVITY NOTICE: This story was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/08/08/davis-r-m-inc-holds-position-in-zimmer-biomet-holdings-inc-zbh.html.

Several equities research analysts recently commented on the company. Royal Bank Of Canada reissued an “outperform” rating and set a $140.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Jefferies Group LLC reissued a “buy” rating and set a $148.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, June 30th. Citigroup Inc. boosted their target price on Zimmer Biomet Holdings from $108.00 to $130.00 and gave the stock a “neutral” rating in a report on Friday, June 9th. Wells Fargo & Company reissued a “market weight” rating on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Finally, Piper Jaffray Companies reissued a “buy” rating and set a $141.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $137.76.

In other Zimmer Biomet Holdings news, insider Sang Yi sold 17,731 shares of the company’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $124.56, for a total value of $2,208,573.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Tony W. Collins sold 16,986 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $121.74, for a total transaction of $2,067,875.64. The disclosure for this sale can be found here. 1.07% of the stock is currently owned by corporate insiders.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.